Parameter der „Small Airway Disease“ verbessern die Differenzierung von Patienten mit leichter COPD und symptomatischen (ex)-Rauchern von Gesunden – Querschnittsdaten aus CAPTO-COPD
F Trinkmann(Hautklinik Heidelberg), H Watz(LungenClinic Grosshansdorf), Felix Herth(Heidelberg University), Klaus F. Rabe(Christian-Albrechts-Universität zu Kiel), Anne‐Marie Kirsten, Mustafa Abdo(Heidelberg University)
Cited by 0
Related Papers
Chronic Obstructive Pulmonary Disease Phenotypes: The Future of COPD
|American Journal of Respiratory and Critical Care Medicine|2010|1k
Outcomes for COPD pharmacological trials: from lung function to biomarkers
|European Respiratory Journal|2008|856
Control of Confounding and Reporting of Results in Causal Inference Studies. Guidance for Authors from Editors of Respiratory, Sleep, and Critical Care Journals
|Annals of the American Thoracic Society|2018|723
Management of COPD exacerbations: a European Respiratory Society/American Thoracic Society guideline
|European Respiratory Journal|2017|679
Dupilumab for COPD with Type 2 Inflammation Indicated by Eosinophil Counts
|New England Journal of Medicine|2023|452